免疫組織化学(IHC)の世界市場分析:製品別(抗体、試薬、装置、キット)、用途別(診断、薬物検査)、エンドユーザー別(病院、診断研究所、研究機関)、セグメント予測、2014-2025...市場調査レポートについてご紹介

【英文タイトル】Immunohistochemistry (IHC) Market Analysis By Product (Antibodies, Reagents, Equipment, Kits), By Application (Diagnostics, Drug Testing), By End-Use (Hospitals, Diagnostic Laboratories, Research Institutes), And Segment Forecasts, 2014-2025

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents

Chapter 1. Methodology and Scope
1.1. Country Wise Market: Base Estimates
1.2. Global Market: CAGR Calculation
1.3. Region Based Segment Share Calculation
1.4. Research Scope & Assumptions
1.5. List of Data Sources
1.5.1. Data for primary interviews, by sources
1.5.2. Data for primary interviews, by region
Chapter 2. Executive Summary
2.1. Market Snapshot
Chapter 3. Immunohistochemistry Market Variables, Trends & Scope
3.1. Market Segmentation & Scope
3.2. Immunohistochemistry: Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Key Opportunities Prioritized
3.3.1. Key opportunities prioritized, by product
3.3.2. Key opportunities prioritized, by application
3.3.3. Key opportunities prioritized, by end-use
3.4. Immunohistochemistry – SWOT Analysis, By Factor (Political & legal, economic and technological)
3.5. Industry Analysis – Porter’s
3.6. Immunohistochemistry Market: Market Position Analysis, 2016
Chapter 4. Immunohistochemistry: Product Estimates & Trend Analysis
4.1. Immunohistochemistry Market: Product Movement Analysis
4.2. Antibodies
4.2.1. Antibodies market estimate & forecast, 2014 – 2025 (USD million)
4.2.2. Primary Antibodies
4.2.2.1. Primary antibodies market estimate & forecast, 2014 – 2025 (USD million)
4.2.3. Secondary Antibodies
4.2.3.1. Secondary antibodies market estimate & forecast, 2014 – 2025 (USD million)
4.3. Reagents
4.3.1. Reagents market estimate & forecast, 2014 – 2025 (USD million)
4.3.2. Histological Stains
4.3.2.1. Histological stains market estimate & forecast, 2014 – 2025 (USD million)
4.3.3. Blocking Sera and Reagents
4.3.3.1. Blocking sera and reagents market estimate & forecast, 2014 – 2025 (USD million)
4.3.4. Chromogenic Substrates
4.3.4.1. Chromogenic substrates market estimate & forecast, 2014 – 2025 (USD million)
4.3.5. Fixation Reagents
4.3.5.1. Fixation reagents market estimate & forecast, 2014 – 2025 (USD million)
4.3.6. Stabilizers
4.3.6.1. Stabilizers market estimate & forecast, 2014 – 2025 (USD million)
4.3.7. Organic Solvents
4.3.7.1. Organic solvents market estimate & forecast, 2014 – 2025 (USD million)
4.3.8. Proteolytic Enzymes
4.3.8.1. Proteolytic enzymes market estimate & forecast, 2014 – 2025 (USD million)
4.3.9. Diluents
4.3.9.1. Diluents market estimate & forecast, 2014 – 2025 (USD million)
4.4. Equipment
4.4.1. Equipment market estimate & forecast, 2014 – 2025 (USD million)
4.4.2. Slide Staining Systems
4.4.2.1. Slide staining systems market estimate & forecast, 2014 – 2025 (USD million)
4.4.3. Tissue Microarrays
4.4.3.1. Tissue microarrays market estimate & forecast, 2014 – 2025 (USD million)
4.4.4. Tissue Processing Systems
4.4.4.1. Tissue processing systems market estimate & forecast, 2014 – 2025 (USD million)
4.4.5. Slide Scanners
4.4.5.1. Slide scanners market estimate & forecast, 2014 – 2025 (USD million)
4.4.6. Others
4.4.6.1. Others market estimate & forecast, 2014 – 2025 (USD million)
4.5. Kits
4.5.1. Kits market estimate & forecast, 2014 – 2025 (USD million)
Chapter 5. Immunohistochemistry: Application Estimates & Trend Analysis
5.1. Immunohistochemistry Market: Application Movement Analysis
5.2. Diagnostics
5.2.1. Diagnostics market estimate & forecast, 2014 – 2025 (USD million)
5.2.2. Cancer
5.2.2.1. Cancer market estimate & forecast, 2014 – 2025 (USD million)
5.2.3. Infectious Diseases
5.2.3.1. Infectious diseases market estimate & forecast, 2014 – 2025 (USD million)
5.2.4. Cardiovascular diseases
5.2.4.1. Cardiovascular diseases market estimate & forecast, 2014 – 2025 (USD million)
5.2.5. Autoimmune Diseases
5.2.5.1. Autoimmune diseases market estimate & forecast, 2014 – 2025 (USD million)
5.2.6. Diabetes Mellitus
5.2.6.1. Diabetes mellitus market estimate & forecast, 2014 – 2025 (USD million)
5.2.7. Nephrological Diseases
5.2.7.1. Nephrological diseases market estimate & forecast, 2014 – 2025 (USD million)
5.3. Drug Testing
5.3.1. Drug testing market estimate & forecast, 2014 – 2025 (USD million)
Chapter 6. Immunohistochemistry: End-Use Estimates & Trend Analysis
6.1. Immunohistochemistry Market: Application Movement Analysis
6.2. Hospitals and Diagnostic Laboratories
6.2.1. Hospitals and diagnostic laboratories market estimate & forecast, 2014 – 2025 (USD million)
6.3. Research Institutes
6.3.1. Research institutes market estimate & forecast, 2014 – 2025 (USD million)
6.4. Others
6.4.1. Others market estimate & forecast, 2014 – 2025 (USD million)
Chapter 7. Immunohistochemistry: Regional Estimates & Trend Analysis, by Product, Application, and End-use
7.1. Immunohistochemistry Market Share (%) Analysis, by Region, 2016 & 2025
7.2. North America
7.2.1. U.S.
7.2.1.1. U.S. immunohistochemistry market, by product, 2014 – 2025 (USD million)
7.2.1.2. U.S. immunohistochemistry market, by application, 2014 – 2025 (USD million)
7.2.1.3. U.S. immunohistochemistry market, by end-use, 2014 – 2025 (USD million)
7.2.2. Canada
7.2.2.1. Canada immunohistochemistry market, by product, 2014 – 2025 (USD million)
7.2.2.2. Canada immunohistochemistry market, by application, 2014 – 2025 (USD million)
7.2.2.3. Canada immunohistochemistry market, by end-use, 2014 – 2025 (USD million)
7.3. Europe
7.3.1. Germany
7.3.1.1. Germany immunohistochemistry market, by product, 2014 – 2025 (USD million)
7.3.1.2. Germany immunohistochemistry market, by application, 2014 – 2025 (USD million)
7.3.1.3. Germany immunohistochemistry market, by end-use, 2014 – 2025 (USD million)
7.3.2. U.K.
7.3.2.1. U.K. immunohistochemistry market, by product, 2014 – 2025 (USD million)
7.3.2.2. U.K. immunohistochemistry market, by application, 2014 – 2025 (USD million)
7.3.2.3. U.K. immunohistochemistry market, by end-use, 2014 – 2025 (USD million)
7.4. Asia Pacific
7.4.1. Japan
7.4.1.1. Japan immunohistochemistry market, by product, 2014 – 2025 (USD million)
7.4.1.2. Japan immunohistochemistry market, by application, 2014 – 2025 (USD million)
7.4.1.3. Japan immunohistochemistry market, by end-use, 2014 – 2025 (USD million)
7.4.2. China
7.4.2.1. China immunohistochemistry market, by product, 2014 – 2025 (USD million)
7.4.2.2. China immunohistochemistry market, by application, 2014 – 2025 (USD million)
7.4.2.3. China immunohistochemistry market, by end-use, 2014 – 2025 (USD million)
7.4.3. India
7.4.3.1. India immunohistochemistry market, by product, 2014 – 2025 (USD million)
7.4.3.2. India immunohistochemistry market, by application, 2014 – 2025 (USD million)
7.4.3.3. India immunohistochemistry market, by end-use, 2014 – 2025 (USD million)
7.5. Latin America
7.5.1. Brazil
7.5.1.1. Brazil immunohistochemistry market, by product, 2014 – 2025 (USD million)
7.5.1.2. Brazil immunohistochemistry market, by application, 2014 – 2025 (USD million)
7.5.1.3. Brazil immunohistochemistry market, by end-use, 2014 – 2025 (USD million)
7.5.2. Mexico
7.5.2.1. Mexico immunohistochemistry market, by product, 2014 – 2025 (USD million)
7.5.2.2. Mexico immunohistochemistry market, by application, 2014 – 2025 (USD million)
7.5.2.3. Mexico immunohistochemistry market, by end-use, 2014 – 2025 (USD million)
7.6. MEA
7.6.1. South Africa
7.6.1.1. South Africa immunohistochemistry market, by product, 2014 – 2025 (USD million)
7.6.1.2. South Africa immunohistochemistry market, by application, 2014 – 2025 (USD million)
7.6.1.3. South Africa immunohistochemistry market, by end-use, 2014 – 2025 (USD million)
Chapter 8. Competitive Landscape
8.1. Company Profiles
8.1.1. CMR Naviscan Corporation
8.1.1.1. Company overview
8.1.1.2. Financial performance
8.1.1.3. Product benchmarking
8.1.1.4. Strategic initiatives
8.1.2. Abcam plc
8.1.2.1. Company overview
8.1.2.2. Financial performance
8.1.2.3. Product benchmarking
8.1.2.4. Strategic initiatives
8.1.3. Agilent Technologies, Inc.
8.1.3.1. Company overview
8.1.3.2. Financial performance
8.1.3.3. Product benchmarking
8.1.3.4. Strategic initiatives
8.1.4. Bio SB Inc.
8.1.4.1. Company overview
8.1.4.2. Financial performance
8.1.4.3. Product benchmarking
8.1.4.4. Strategic initiatives
8.1.5. Bio-Rad Laboratories, Inc.
8.1.5.1. Company overview
8.1.5.2. Financial performance
8.1.5.3. Product benchmarking
8.1.5.4. Strategic initiatives
8.1.6. Cell Signaling Technology, Inc.
8.1.6.1. Company overview
8.1.6.2. Financial performance
8.1.6.3. Product benchmarking
8.1.6.4. Strategic initiatives
8.1.7. Danaher Corporation
8.1.7.1. Company overview
8.1.7.2. Financial performance
8.1.7.3. Product benchmarking
8.1.7.4. Strategic initiatives
8.1.8. F. Hoffmann-La Roche AG
8.1.8.1. Company overview
8.1.8.2. Financial performance
8.1.8.3. Product benchmarking
8.1.8.4. Strategic initiatives
8.1.9. Merck Millipore
8.1.9.1. Company overview
8.1.9.2. Financial performance
8.1.9.3. Product benchmarking
8.1.9.4. Strategic initiatives
8.1.10. PerkinElmer, Inc.
8.1.10.1. Company overview
8.1.10.2. Financial performance
8.1.10.3. Product benchmarking
8.1.10.4. Strategic initiatives
8.1.11. Thermo Fisher Scientific Inc.
8.1.11.1. Company overview
8.1.11.2. Financial performance
8.1.11.3. Product benchmarking
8.1.11.4. Strategic initiatives


【レポート販売概要】

■ タイトル:免疫組織化学(IHC)の世界市場分析:製品別(抗体、試薬、装置、キット)、用途別(診断、薬物検査)、エンドユーザー別(病院、診断研究所、研究機関)、セグメント予測、2014-2025
■ 英文:Immunohistochemistry (IHC) Market Analysis By Product (Antibodies, Reagents, Equipment, Kits), By Application (Diagnostics, Drug Testing), By End-Use (Hospitals, Diagnostic Laboratories, Research Institutes), And Segment Forecasts, 2014-2025
■ 発行日:2017年3月9日
■ 調査会社:Grand View Research
■ 商品コード:GVIEW707422
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。